Ravicti 1.1 g

RAVICTI 1.1 G is a liquid formulation of glycerol phenylbutyrate used for managing certain metabolic conditions. This oral solution is designed to support patients requiring specialized care.

RAVICTI 1.1 G is primarily used to manage urea cycle disorders, which are conditions that affect the body's ability to remove ammonia from the bloodstream. This liquid formulation helps to reduce ammonia levels, supporting overall metabolic health. Patients often seek information on 'what is glycerol phenylbutyrate used for' when exploring treatment options for these disorders.

Common effects of RAVICTI 1.1 G may include gastrointestinal discomfort, such as nausea or vomiting. Some users might experience changes in appetite or taste. These effects can vary among individuals and are generally mild to moderate in nature.

RAVICTI 1.1 G should be handled with care, ensuring it is stored properly and administered as directed. It is important to follow the guidance of a healthcare provider regarding its use. Patients should be aware of potential interactions with other medications and should discuss their full medical history with their healthcare provider.

RAVICTI 1.1 G may interact with certain medications, including those that affect liver function or metabolism. It is advisable to avoid alcohol while using this medication, as it can exacerbate side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.